Core Insights - OptimumBank Holdings, Inc. reported net earnings of $4.85 million for Q4 2025, an increase from $4.32 million in Q3 2025 and $3.95 million in Q4 2024, driven by improved net interest income and noninterest income [1][15][22]. Financial Performance - Net interest income for Q4 2025 was $11.87 million, up from $11.05 million in Q3 2025 and $9.24 million in Q4 2024, supported by higher loan yields and lower costs on interest-bearing liabilities [5][17]. - Noninterest income decreased to $1.73 million in Q4 2025 from $1.98 million in Q3 2025, primarily due to fewer loan prepayment fees [6][22]. - Total noninterest expenses increased to $6.74 million in Q4 2025, compared to $6.60 million in Q3 2025 and $4.38 million in Q4 2024, reflecting higher employee compensation and marketing expenses [6][23][24]. Balance Sheet Highlights - Total assets grew to $1.11 billion as of December 31, 2025, up from $1.08 billion at September 30, 2025, and $932.93 million at December 31, 2024 [7][26]. - Total gross loans increased to $958.79 million at December 31, 2025, from $813.72 million at September 30, 2025, and $804.24 million at December 31, 2024, driven by growth in commercial and residential real estate [2][29]. - Total deposits decreased to $931.75 million at December 31, 2025, from $959.49 million at September 30, 2025, but increased from $772.20 million at December 31, 2024 [10][34]. Capital and Credit Quality - The allowance for credit losses was $10.27 million, or 1.07% of total loans, as of December 31, 2025, reflecting a well-managed loan portfolio [8][30]. - Nonaccrual loans decreased to $2.90 million at December 31, 2025, from $7.58 million at December 31, 2024, indicating improved asset quality [33]. Strategic Outlook - The Company plans to expand into new financial verticals that complement its banking operations, with a new subsidiary expected to launch in 2026 [5][12].

SEATTLE, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatments for cancers throughout the body, today announced the pricing of an underwritten offering of 39,576,088 shares of its common stock at an offering price of $3.79 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 6,598,046 shares of its common stock at a price of $3.789 pe ...

CORSICANA, Texas, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (“Birchtech” or the “Company”), a leader in specialty activated carbon technologies for sustainable air and water treatment, today announced that on February 2, 2026, Birchtech formally requested payment of its $78 million judgment against the CERT entities in its Delaware litigation. On December 29, 2025, the U.S. District Court of Delaware issued a final judgment of $78 million against the “CERT” Defendants follo ...

Atlanta, GA, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Trust Stamp, a global provider of AI-powered trust, identity and security solutions provided an overview of business progress for January 2026. Gareth N. Genner, Chief Executive Officer of Trust Stamp reported: “In Q4 of 2025 we completed a financing round using a combination of market placements of stock using our S3 capacity and a warrant inducement agreement. The objective of the financing was to provide working capital to give us the ability to achieve sign ...

Core Insights - Aeries Technology, Inc. has announced a multi-year, multi-million-dollar engagement with a leading global financial services firm to establish a Global Capability Center in Bangalore [1][2] - The center will focus on developing the client's next-generation platform and modernizing its core digital infrastructure, leveraging India's engineering talent [2][3] - This partnership reflects the trend among global financial institutions to adopt cloud solutions and undergo large-scale digital transformations [3] Company Strategy - Aeries is building a specialized engineering team in Bangalore that will enhance platform engineering, cloud infrastructure, and data capabilities [4] - The establishment of the center is part of Aeries' broader strategy to scale premium technology delivery through innovation-led Global Capability Center operations [4] - The partnership includes a structured growth pathway, allowing the center to expand based on delivery performance and client priorities, ensuring long-term value creation [4] Company Background - Aeries Technology is recognized as a leader in AI-enabled value creation and business transformation, particularly for private equity portfolio companies [5] - Founded in 2012, the company has received Great Place to Work Certification for three consecutive years, highlighting its commitment to workforce development [5]

Prestigious honor affirms international acclaim for the company's comprehensive and long-term commitment to sustainable developmentKEY POINTS Global Sustainability Leadership: ASUS was the only Taiwanese company listed in the award category "Computers and Peripheral Equipment"Eco-Friendly Product Success: Sustainability drives ASUS design, resulting in 89% eco-friendly product revenue and EPEAT Climate+ Champion statusTop-Tier Climate Governance: Achieved CDP Double 'A' (climate change, water security) via ...

BOCA RATON, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) retired $95 million of fixed rate senior notes that matured on February 1, 2026. The 5-year notes, which were publicly traded under the ticker symbol “NEWTZ”, were issued in 2021. The Company funded the $95.0 million repayment with $87.1 million of working capital and a recently completed exchange offer pursuant to which the Company exchanged $7.9 million of NEWTZ notes for a like amount of newly issued NEWTO ...

Management to Engage with Global Clinical Research Leaders Ahead of Phase 2a Trial of Concussion Treatment Sarasota, Fla., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the “Company”), a clinical-stage biotechnology company focused on developing intranasal therapeutics for neurological disorders, today announced its participation at the SCOPE Summit 2026, the 17th annual conference organized by the Cambridge Healthtech Institute. SCOPE (Summit for Clinical Ops Executives) is a cl ...

GRAND CAYMAN, Cayman Islands, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Patria Investments Limited (“Patria”) (NASDAQ: PAX) announced today that it has changed the date it will release financial results for the fourth quarter and full year 2025 from Tuesday, February 10, 2026, to Tuesday, February 3, 2026, and will host a conference call via public webcast at 9:00 a.m. ET. To register, please use the following link: https://edge.media-server.com/mmc/p/r9ysrjme For those unable to listen to the live broadcast, there ...

BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced its Board of Directors has approved a share repurchase program, which authorizes the Company to repurchase up to $75 million of the Company’s outstanding common stock. The repurchase program is authorized through December 31, 2027. “With a strong balance sheet, s ...